iiinova — where your digital self keeps evolving

Blanca A-G

@blanka-g.bsky.social

19 followers 49 following 4 posts

Posts Replies Media

Blanca A-G @blanka-g.bsky.social · 13/05/2026

@eye-tuebingen.bsky.social Congratulations to our student Katharina Kock on receiving the 1st Poster Prize from the Faculty of Medicine at the University of Tübingen! Very proud to see her excellent work on retinal degeneration and VCP recognized. A truly well-deserved achievement. 🎉

Blanca A-G @blanka-g.bsky.social · 03/02/2026

Happy to share our new article in Journal of Controlled Release on the protective effect of VCP inhibition on retinal degeneration Congratulations to our student Bowen Cao for her excellent work, and many thanks to all coauthors for the great collaboration. www.sciencedirect.com/science/arti...

sciencedirect.com

Ocular delivery of different valosin-containing protein (VCP) inhibitory formulations prevents retinal degeneration in rho∆I255 mice

Rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) is a progressive inherited retinal degenerative disorder currently lacking effec…

Reposted by Blanca A-G

Institute for Ophthalmic Research in Tübingen @eye-tuebingen.bsky.social · 27/01/2026

For PhD studs, postdocs. Cutting-edge retina research, from physiology to disease mechanisms. Strong involvement from IOR in Tübingen, highlighting commitment to training the next generation of vision scientists! @blanka-g.bsky.social @unituebingen.bsky.social www.eye-tuebingen.de?tx_news_pi1%...

eye-tuebingen.de

Retina in a Dish: Advanced Ex-Vivo Methods for Retina Research

The active representation of the Institute for Ophthalmic Research in Tübingen, represents the strategic focus on retina physiology and disease mechanisms, as well as its commitment to training the ne...

Blanca A-G @blanka-g.bsky.social · 16/01/2026

Excited to share that our research is now published! Huge congrats to Ana C. Almansa García, and many thanks to Marius Ueffing, Angela Armento, and all co-authors! 🔗 link.springer.com/article/10.1... @eye-tuebingen.bsky.social #Proteostasis #VCP #RetinalDegeneration #PreclinicalResearch

link.springer.com

Safety and neuroprotective efficacy of the VCP inhibitor ML240 in large-animal and human retinal explants: a preclinical ex vivo study - BMC Medicine

Background Retinal degenerative diseases represent a complex global health problem due to their significant impact on patients’ daily lives and their highly heterogeneous pathogenesis, which challenge...

000